Don't think that is too much of a problem as it creates a buying...

Don't think that is too much of a problem as it creates a buying opportunity for those who missed out lower down. They moved pretty quickly from $1.64 yesterday and caught some of us out. My buy is in at $1.63 and the sp didn't quite make it, got some the previous day but not all. With the latest announcement from management it looks like we are back on track. I was worried that the assay results were being withheld because they were poor, but that fear has been removed. The placement was never a problem imo. These are now a huge buy below $2, if you can get them.